These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 16107293)

  • 1. Poor antibody response to pneumococcal polysaccharide vaccination suggests increased susceptibility to pneumococcal infection in splenectomized patients with hematological diseases.
    Cherif H; Landgren O; Konradsen HB; Kalin M; Björkholm M
    Vaccine; 2006 Jan; 24(1):75-81. PubMed ID: 16107293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin's lymphoma.
    Landgren O; Björkholm M; Konradsen HB; Söderqvist M; Nilsson B; Gustavsson A; Axdorph U; Kalin M; Grimfors G
    J Intern Med; 2004 Jun; 255(6):664-73. PubMed ID: 15147530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults.
    Musher DM; Manof SB; Liss C; McFetridge RD; Marchese RD; Bushnell B; Alvarez F; Painter C; Blum MD; Silber JL
    J Infect Dis; 2010 Feb; 201(4):516-24. PubMed ID: 20092407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody response to pneumococcal vaccine in splenectomized children.
    Pedersen FK
    Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):169-80. PubMed ID: 6880749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revaccination with a 23-valent pneumococcal polysaccharide vaccine induces elevated and persistent functional antibody responses in adults aged 65 > or = years.
    Manoff SB; Liss C; Caulfield MJ; Marchese RD; Silber J; Boslego J; Romero-Steiner S; Rajam G; Glass NE; Whitney CG; Carlone GM
    J Infect Dis; 2010 Feb; 201(4):525-33. PubMed ID: 20088694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological responses to pneumococcal vaccine in frail older people.
    Ridda I; Macintyre CR; Lindley R; Gao Z; Sullivan JS; Yuan FF; McIntyre PB
    Vaccine; 2009 Mar; 27(10):1628-36. PubMed ID: 19100304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody response to pneumococcal vaccine in middle-aged and elderly patients recently treated for pneumonia.
    Hedlund JU; Kalin ME; Ortqvist AB; Henrichsen J
    Arch Intern Med; 1994 Sep; 154(17):1961-5. PubMed ID: 8074600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised revaccination with pneumococcal polysaccharide or conjugate vaccine in asplenic children previously vaccinated with polysaccharide vaccine.
    Smets F; Bourgois A; Vermylen C; Brichard B; Slacmuylders P; Leyman S; Sokal E
    Vaccine; 2007 Jul; 25(29):5278-82. PubMed ID: 17576024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of antibody response to pneumococcal capsular polysaccharides in vaccinated long term-care residents in Brazil.
    Brandão AP; de Oliveira TC; de Cunto Brandileone MC; Gonçalves JE; Yara TI; Simonsen V
    Vaccine; 2004 Dec; 23(6):762-8. PubMed ID: 15542200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody response to pneumococcal capsular polysaccharide vaccination in patients with chronic kidney disease.
    Mahmoodi M; Aghamohammadi A; Rezaei N; Lessan-Pezeshki M; Pourmand G; Mohagheghi MA; Abdollahzade S; Mousavi-Jarrahi A
    Eur Cytokine Netw; 2009 Jun; 20(2):69-74. PubMed ID: 19541592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pneumococcal vaccination of splenectomized patients. Recommendations based on a 10-year experience].
    Konradsen HB; Henrichsen J
    Ugeskr Laeger; 1991 Oct; 153(43):2999-301. PubMed ID: 1801383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis.
    Kapetanovic MC; Saxne T; Sjöholm A; Truedsson L; Jönsson G; Geborek P
    Rheumatology (Oxford); 2006 Jan; 45(1):106-11. PubMed ID: 16287919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and immunogenicity of Pneumo-23 and ACT-HIB in patients undergoing splenectomy.
    Uslu A; Yetiş H; Aykas A; Karagöz A; Doğan M; Simşek C; Nart A; Yüzbaşioğlu MF
    Ulus Travma Acil Cerrahi Derg; 2006 Oct; 12(4):277-81. PubMed ID: 17029117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type-specific antibodies to pneumococcal capsular polysaccharide acquired either naturally or after vaccination with Prevenar in children with underlying chronic or recurrent lung diseases.
    Navarro D; Escribano A; Cebrián L; Gimeno C; García-Maset L; García-de-Lomas J;
    Clin Vaccine Immunol; 2006 Jun; 13(6):665-70. PubMed ID: 16760325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of sequential pneumococcal vaccination in subjects splenectomised for hereditary spherocytosis.
    Stoehr GA; Rose MA; Eber SW; Heidemann K; Schubert R; Zielen S
    Br J Haematol; 2006 Mar; 132(6):788-90. PubMed ID: 16487181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can the response to 23-valent pneumococcal vaccine in splenectomised patients be predicted?
    Llupià A; Vilella A; Costas L; Díez C; Torres F; Yagüe J; Massó M; Muñoz A; Mensa J
    Vaccine; 2012 Mar; 30(13):2382-6. PubMed ID: 21964060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of protein-conjugate pneumococcal vaccine to patients who have invasive disease after splenectomy despite their having received 23-valent pneumococcal polysaccharide vaccine.
    Musher DM; Ceasar H; Kojic EM; Musher BL; Gathe JC; Romero-Steiner S; White AC
    J Infect Dis; 2005 Apr; 191(7):1063-7. PubMed ID: 15747240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumococcal vaccination in splenectomised cancer patients.
    Omlin AG; Mühlemann K; Fey MF; Pabst T
    Eur J Cancer; 2005 Aug; 41(12):1731-4. PubMed ID: 16026979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumococcal vaccine in children and young adults with chronic renal disease.
    Fuchshuber A; Kühnemund O; Keuth B; Lütticken R; Michalk D; Querfeld U
    Nephrol Dial Transplant; 1996 Mar; 11(3):468-73. PubMed ID: 8671817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeat revaccination with 23-valent pneumococcal polysaccharide vaccine among adults aged 55-74 years living in Alaska: no evidence of hyporesponsiveness.
    Hammitt LL; Bulkow LR; Singleton RJ; Nuorti JP; Hummel KB; Miernyk KM; Zanis C; Whaley M; Romero-Steiner S; Butler JC; Rudolph K; Hennessy TW
    Vaccine; 2011 Mar; 29(12):2287-95. PubMed ID: 21255685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.